Anemia in Pediatric Inflammatory Bowel Disease

Ghanim Aljomah1, Susan S Baker1, Kenneth Schmidt2

  • 1Digestive Diseases & Nutrition Center, Women & Children's Hospital of Buffalo, SUNY at Buffalo.

Insights

Anemia is common in pediatric inflammatory bowel disease (IBD), affecting over 67% at diagnosis. While anemia prevalence decreased at 1 year, it persisted, with anemia of chronic disease being most common in Crohn disease.

Area of Science:

  • Pediatric Gastroenterology
  • Hematology
  • Inflammatory Bowel Disease (IBD) Research

Background:

  • Anemia is a frequent extra-intestinal manifestation in pediatric patients with Inflammatory Bowel Disease (IBD).
  • Understanding the prevalence and types of anemia at diagnosis and during follow-up is crucial for effective management.

Purpose of the Study:

  • To determine the prevalence and types of anemia in pediatric patients diagnosed with IBD.
  • To assess anemia at diagnosis and approximately one year post-diagnosis.

Main Methods:

  • Retrospective chart review of pediatric IBD patients (ages 1-18) diagnosed between 2005-2012.
  • Inclusion criteria: hemoglobin, hematocrit, MCV, and iron indices at diagnosis and 1-year follow-up.
  • Anemia typing utilized the soluble transferrin receptor index.

Main Results:

  • At diagnosis, 67.31% of pediatric IBD patients had anemia.
  • Iron deficiency anemia (IDA) or combined IDA/anemia of chronic disease (ACD) affected 28.85%, while 38.46% had ACD alone.
  • At 1-year follow-up, anemia prevalence decreased to 20.51%, with 15.38% having IDA or combined IDA/ACD and 5.13% having ACD alone.

Conclusions:

  • Anemia is highly prevalent in pediatric IBD, particularly in Crohn disease (CD).
  • Anemia significantly decreased but persisted at 1 year post-diagnosis.
  • Anemia of chronic disease was predominant in CD, while IDA persisted in both CD and ulcerative colitis.
Abstract

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.2K
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.1K
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
639
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
718
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
848
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
17.0K